Works matching IS 13520504 AND DT 2010 AND VI 17 AND IP 4

Results: 11

Treatment of chronic hepatitis C in polytransfused thalassaemic patients: a meta-analysis.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 236, doi. 10.1111/j.1365-2893.2009.01170.x

By:

Alavian, S.-M.;
Tabatabaei, S.-V.

Publication type:

Article

Clearance of hepatitis C in chimpanzees is associated with intrahepatic T-cell perforin expression during the late acute phase.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 245, doi. 10.1111/j.1365-2893.2009.01172.x

By:

Watanabe, H.;
Wells, F.;
Major, M. E.

Publication type:

Article

Visfatin serum levels in chronic hepatitis C patients.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 254, doi. 10.1111/j.1365-2893.2009.01174.x

By:

Kukla, M.;
Żwirska-Korczala, K.;
Gabriel, A.;
Waluga, M.;
Warakomska, I.;
Berdowska, A.;
Rybus-Kalinowska, B.;
Kalinowski, M.;
Janczewska-Kazek, E.;
Woźniak-Grygiel, E.;
Kryczka, W.

Publication type:

Article

Mortality in HIV-infected injection drug users with active vs cleared hepatitis C virus-infection: a population-based cohort study.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 261, doi. 10.1111/j.1365-2893.2009.01175.x

By:

Omland, L. H.;
Jepsen, P.;
Weis, N.;
Christensen, P. B.;
Laursen, A. L.;
Nielsen, H.;
Krarup, H.;
Sørensen, H. T.;
Obel, N.

Publication type:

Article

Hepatitis A disease following the implementation of universal vaccination: Who is at risk?

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 293, doi. 10.1111/j.1365-2893.2009.01176.x

By:

Mor, Z.;
Srur, S.;
Dagan, R.;
Rishpon, S.

Publication type:

Article

Adjuvant therapy used in conjunction with combination therapy for chronic hepatitis C improves sustained virus response rates in genotype 1 patients.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 269, doi. 10.1111/j.1365-2893.2009.01177.x

By:

Cash, W. J.;
Patterson, K.;
Callender, M. E.;
McDougall, N. I.

Publication type:

Article

Stringent cessation criterion results in better durability of lamivudine treatment: a prospective clinical study in hepatitis B e antigen-positive chronic hepatitis B patients.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 298, doi. 10.1111/j.1365-2893.2009.01178.x

By:

Wang, L.;
Liu, F.;
Liu, Y.-D.;
Li, X.-Y.;
Wang, J.-B.;
Zhang, Z.-H.;
Wang, Y.-Z.

Publication type:

Article

Association between lipoprotein subfraction profile and the response to hepatitis C treatment in Japanese patients with genotype 1b.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 274, doi. 10.1111/j.1365-2893.2009.01179.x

By:

Mawatari, H.;
Yoneda, M.;
Fujita, K.;
Nozaki, Y.;
Shinohara, Y.;
Sasaki, H.;
Iida, H.;
Takahashi, H.;
Inamori, M.;
Abe, Y.;
Kobayashi, N.;
Kubota, K.;
Kirikoshi, H.;
Nakajima, A.;
Saito, S.

Publication type:

Article

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 280, doi. 10.1111/j.1365-2893.2009.01180.x

By:

Sánchez-Conde, M.;
Montes-Ramírez, M. L.;
Miralles, P.;
Alvarez, J. M. Castro;
Bellón, J. M.;
Ramírez, M.;
Arribas, J. R.;
Gutiérrez, I.;
López, J. C.;
Cosín, J.;
Alvarez, E.;
González, J.;
Berenguer, J.

Publication type:

Article

Meta-analysis: interferon-alpha prevents the recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 287, doi. 10.1111/j.1365-2893.2009.01181.x

By:

Miyake, Y.;
Takaki, A.;
Iwasaki, Y.;
Yamamoto, K.

Publication type:

Article

Hepatitis B virus: origin and evolution.

Published in:

Journal of Viral Hepatitis, 2010, v. 17, n. 4, p. 229, doi. 10.1111/j.1365-2893.2009.01193.x

By:

Jazayeri, S. M.;
Alavian, S. M.;
Carman, W. F.

Publication type:

Article